Characterization of a Mutated IgA2 Antibody of the m(1) Allotype against the Epidermal Growth Factor Receptor for the Recruitment of Monocytes and Macrophages-Reference-Cited by-同舟云学术

Characterization of a Mutated IgA2 Antibody of the m(1) Allotype against the Epidermal Growth Factor Receptor for the Recruitment of Monocytes and Macrophages

Published:2012-07 Issue:30 Volume:287 Page:25139-25150
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Lohse Stefan,Brunke Christina,Derer Stefanie,Peipp Matthias,Boross Peter,Kellner Christian,Beyer Thomas,Dechant Michael,van der Winkel Jan G.J.,Leusen Jeanette H.W.,Valerius Thomas

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference49 articles.

1. Antibody-based therapeutics to watch in 2011;Reichert;MAbs.,2011

2. Potent antibody therapeutics by design;Carter;Nat. Rev. Immunol.,2006

3. Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies;Brüggemann;J. Exp. Med.,1987

4. Chimeric IgA antibodies against HLA class II effectively trigger lymphoma cell killing;Dechant;Blood.,2002

5. Multiple roles for the major histocompatibility complex class I-related receptor FcRn;Ghetie;Annu. Rev. Immunol.,2000

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing Neutrophil Cytotoxicity of a Panel of Clinical EGFR Antibodies by Fc Engineering to IgA3.0;Molecular Cancer Therapeutics;2024-07-03

2. Stability Engineering of Recombinant Secretory IgA;International Journal of Molecular Sciences;2024-06-22

3. Engineering Dimeric EGFR-directed IgA Antibodies Reveals a Central Role of CD147 during Neutrophil-mediated Tumor Cell Killing of Head and Neck Squamous Cancer Cells;The Journal of Immunology;2024-05-24

4. IgA antibody immunotherapy targeting GD2 is effective in preclinical neuroblastoma models;Journal for ImmunoTherapy of Cancer;2023-07

5. Hepatoblastoma exhibits a predominantly myeloid immune landscape and reveals opportunities for macrophage targeted immunotherapy;2023-06-28